View the latest Sage Therapeutics Inc. (SAGE) stock price, news, historical charts, analyst ratings and financial information from WSJ.

On behalf of Sage shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and ...

Investing.com - Scotiabank (TSX: BNS) downgraded Sage Therapeutics (NASDAQ: SAGE) from Sector Outperform to Sector Perform on Tuesday, while lowering its price target to $9.20 from $12.00. The stock, ...

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain.